CD274 and cancer: Interestingly, the immune system itself can target regulatory cells, and naturally occurring T cells specific to epitopes from pivotal immune regulatory proteins such as indoleamine 2,3-dioxygenase, PD-L1, PD-L2 and ARG1 have been described in cancer patients [126,127,128,129].